Cancer and Disease Research Panel Headlines ISSRDC Day One Keynote
Cancer and disease research on the International Space Station (ISS) is of critical importance to NASA and the worldwide medical community. This year, the 12th annual International Space Station Research and Development Conference (ISSRDC) takes aim at deadly diseases with its Day 1 keynote panel, “Igniting Innovation to Accelerate Disease Research on the ISS.”
The American Cancer Society estimates that there will be nearly two million new cases of cancer diagnosed in 2023, and more than half a million cancer-related deaths.
The cancer and disease research panel will be moderated by Ezinne Uzo-Okoro, the assistant director for space policy in the White House Office of Science and Technology Policy (OSTP). In 2022, The White House unveiled Cancer Moonshot—an initiative to bring renewed leadership to the fight against cancer. Joining Uzo-Okoro on this panel are Lisa Carnell, division director of Biological and Physical Sciences at NASA, and Michael Roberts, chief scientific officer at the ISS National Laboratory.
Cancer and Disease Research in LEO
This conversation on cancer and disease research will explore how the National Low Earth Orbit Research and Development Strategy positions the microgravity research community to uniquely contribute to the success of cancer and other disease treatment innovation, and facilitates the development of therapeutics with results that benefit humanity and improve the quality of life for patients on Earth.
The Day 1 morning keynote panel kicks off ISSRDC 2023, the annual conference that brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the space station. ISSRDC will showcase how the space station continues to provide a valuable platform for research and technology development that benefits humanity and enables a robust and sustainable market in low Earth orbit.
The conference is hosted by the ISS National Laboratory, managed by the Center for the Advancement of Science in Space, Inc. (CASIS); NASA; and the American Astronautical Society (AAS) at the Hyatt Regency Seattle July 31-August 3, 2023.
(Source: ISS National Laboratory news release. Images provided and from file)